NANOBEAK BIOTECH INC REVIEW
This complaint was posted on NAS on 6th Jan, 2021 and is a permanent record located here: https://www.nameandshame.com/nanobeak-biotech-inc-5YCWL/company-run-by-frauds-id5ydqf .
A Company Run By Frauds
Today, The Smart Investor Feed brings you another morally reprehensible fraud.
Nanobeak Biotech Inc has been seized/arrested by the U.S. Securities And Exchange Commission (SEC). Shocking right?
We weren’t expecting this as well, but these scammers are getting smarter by the minute, making it harder for us to identify.
Such swindlers seem to be booming in numbers lately. This case is kind of interesting, why don’t I show you why:
Full Report On Nanobeak Biotech Inc
The Securities and Exchange Commission today charged J. Jeremy Barbera, a recidivist securities law violator and the former CEO of Nanobeak Biotech Inc., Carl Smith, a stock promoter, and Nanobeak with defrauding investors of approximately $3.6 million.
According to the SEC's complaint, between at least December 2015 and December 2019, Barbera, a New York City resident, and Nanobeak, a private Delaware company located in New York City, made false and misleading statements about the company's business while soliciting, and selling Nanobeak securities to, investors and potential investors. For example, the complaint alleges that Barbera and Nanobeak claimed that Nanobeak was working in conjunction with scientists at NASA and a nationally recognized research university, and that it had developed a sensor device that used a breathalyzer test to detect cancer and drug use. The complaint alleges that, in reality, Nanobeak never developed any such technology. The complaint further alleges that Barbera used at least $1.6 million, or nearly 45% of investor funds, for his own personal benefit. As alleged, after Barbera resigned as Nanobeak's CEO in April 2019, he enlisted Smith, a Sarasota, Florida resident, to sell Nanobeak securities. According to the complaint, Smith falsely told investors that he was a Nanobeak employee, that all investor funds would be used to benefit Nanobeak, and that he was not accepting compensation or taking commissions, when in fact, Smith was never a Nanobeak employee, and in 2019 he received at least $173,000 of investor funds purportedly raised for Nanobeak for his own personal benefit.
The SEC's complaint, filed in federal district court in Manhattan, charges Barbera, Smith and Nanobeak with violations of the antifraud provisions of Section 17(a) of the Securities Act of 1933 and Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder, and, additionally, charges Smith with aiding and abetting Barbera's violations. The SEC is seeking a final judgment ordering permanent injunctive relief, disgorgement plus prejudgment interest thereon, and civil monetary penalties.
Separately, the United States Attorney's Office for the Southern District of New York announced criminal charges against Barbera.
Conclusion: Nanobeak Biotech Inc Is A Fraud
The report on SEC clearly suggests that Nanobeak Biotech Inc never had any intentions to do honest business or provide helpful services. Main intention behind all their actions was to take advantage of the honesty & gullibility of people and scam them. It would be an understatement to call this a mere fraud, this one is a scandal.
If you feel like you are a victim of this scam, then I recommend contacting a law firm and consulting with them about a lawsuit. Companies & firms pay huge reprimands to settle serious lawsuits.
Help Us Fight These Criminals
Do you have evidence against Nanobeak Biotech Inc or one of their associates, then please post it here. These criminals rely on their witnesses’ & victims’ silence, if you speak up, then they get exposed and punished for their horrific acts. I started The Smart Investor Feed on this site with only one purpose; to become a nightmare for the financial frauds in the country. I try to post often, so you can bookmark my profile for regular updates on frauds & con-artists.
Full Disclosure: We sourced this piece of information from the SEC database